Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus PPG Q1 2026 Earnings Earnings Beat Expectations Amid Operational Discipline BRFH Q1 2026 Earnings Surpasses EPS Estimates with Narrower Loss III Q1 2026 Earnings EPS Surpasses Estimates by 17 as Stock Edges Higher Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses Preferred Bank PFBC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Stable Operating Performance